Showing results (141-150 of 4,510) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|October 7, 2017
The expression profile and clinicopathological significance of Notch1 in patients with colorectal cancer: a meta-analysisGanxiong Li, Zheng Zhou, Hongrun Zhou, et al.
Future Oncology (London, England)|October 7, 2017
Sanger Institute series: uncovering the genetics of cancer: an interview with David AdamsDavid J Adams
Future Oncology (London, England)|February 4, 2017
A multinational report of technical factors on stereotactic body radiotherapy for oligometastasesKristin J Redmond, Simon S Lo, Roi Dagan, et al.
Future Oncology (London, England)|July 25, 2019
Fertility preservation strategies for rectal cancer in reproductive-age womenSamuel Khiat, Pauline Bottin, Jacqueline Saïas-Magnan, et al.
Future Oncology (London, England)|March 14, 2019
The 21-gene recurrence score and effects of adjuvant radiotherapy after breast conserving surgery in early-stage breast cancerYong Dong, Wen-Wen Zhang, Jun Wang, et al.
Future Oncology (London, England)|March 19, 2019
Tumor-induced mortality in adult primary supratentorial glioblastoma multiforme with different age subgroupsChang Shu, Xiaoling Yan, Xuebin Zhang, et al.
Future Oncology (London, England)|September 11, 2019
Treatment of advanced soft tissue sarcoma by histological subtype: wish, prediction or reality?Jean-Yves Blay
Future Oncology (London, England)|September 24, 2019
Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancerPriyanka Bobbili, Kellie Ryan, Mei S Duh, et al.
Future Oncology (London, England)|August 20, 2019
Cancer immunotherapy-associated hypophysitisFranklin Castillero, Omar Castillo-Fernández, Geiner Jiménez-Jiménez, et al.
Future Oncology (London, England)|August 21, 2019
EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancerAditya Bardia, Philippe Aftimos, Teeru Bihani, et al.
Pageof 451